Meegan Carter, Norman Regional Vice President of Health and Wellness, and state Sen. Rob Standridge, R- Norman, a local pharmacist, spoke to the Cleveland County Board of Commissioners recently about the benefits of Monoclonal Antibody Therapy.
While the treatment has been available for high risk patients age 18 and older for some time, it is now available to a wider range of people. Standridge asked the Board of County Commissioners to help get the word out about this available therapy after he learned that many Oklahomans are not aware this help is available.
“As we see in Oklahoma and other states, often citizens infected or exposed to COVID wait much too long before they receive their first treatments leading to a much greater percentage of those hospitalized than should happen, and, unfortunately, we see more deaths than we should,” Standridge said. “I believe Cleveland County has the leadership and the influence to truly make a difference, and I am excited to partner with my friends in Cleveland County to truly help those citizens who are or will be impacted.”
The infusion therapy has been authorized for emergency use by the FDA and advocates say it has helped keep people out of the hospital. Patients must have a positive COVID test and treatment must be administered within 10 days of first experiencing COVID-19 symptoms. Patients should weigh at least 88 pounds and meet at least one of the high-risk categories for progressing to severe COVID-19.
For more information on monoclonal antibody therapy, talk to your local health provider about the treatment and a referral or contact the Norman Regional Same Day clinic, 405-515-6246, to be seen virtually and receive a referral.
Read here for more information on Cleveland County's COVID-19 response.